# Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

> **NCT00061035** · PHASE1 · COMPLETED · sponsor: **Cosmo Bioscience** · enrollment: 18 (estimated)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **BIOLOGICAL:** Transgenic Lymphocyte Immunization Vaccine (TLI)

## Key facts

- **NCT ID:** NCT00061035
- **Lead sponsor:** Cosmo Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2008-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00061035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00061035, "Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00061035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*